Inkmet P 2mg/500mg/15mg Tablet SR

Overview Inkmet P 2mg/500mg/15mg Tablet SR

Metformin/Pioglitazone/Sitagliptin extended-release tablets (2mg/500mg/15mg) manage blood glucose in adults with type 2 diabetes. This combination therapy, used alongside diet and exercise, enhances insulin effectiveness and reduces blood sugar. Dosage and duration should strictly follow your physician's instructions. Take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Excessive medication can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Disclose kidney, liver, or heart conditions before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Kidney function tests are typically performed before initiating therapy. Limit alcohol consumption to mitigate potential side effects.

Primary Ingredients of Inkmet P 2mg/500mg/15mg Tablet SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Inkmet P 2mg/500mg/15mg Tablet SR

Managing type 2 diabetes

Major Benefits of Inkmet P 2mg/500mg/15mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Inkmet P 2mg/500mg/15mg Tablet SR whole; do not crush, chew, or divide it. This extended-release tablet should be administered with food.

Common Side effects of Inkmet P 2mg/500mg/15mg Tablet SR:

• Hypoglycemia (low blood glucose level)
• Headache
• Nausea
• Diarrhea
• Dizziness
• Vomiting
• Anemia (low number of red blood cells)
• Weakness
• Sinus infection

How to use Inkmet P 2mg/500mg/15mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. Inkmet P 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.

How Inkmet P 2mg/500mg/15mg Tablet SR works:

Inkmet P SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.

What if you forget to take Inkmet P 2mg/500mg/15mg Tablet SR :

Should you forget a dose of Inkmet P 2mg/500mg/15mg Tablet SR, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.